NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

PTHL

Pheton Holdings Ltd

May 22 • 04:00PM ET

6.08

Dollar change +0.68
Percentage change 12.59	%

Healthcare • Medical Devices • China • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.05	Insider Own	84.21%	Shs Outstand	6.58M	Perf Week	13.64%
Market Cap	86.64M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	2.25M	Perf Month	123.53%
Income	-0.66M	PEG	-	EPS next Q	-	Inst Own	0.12%	Short Float	1.53%	Perf Quarter	102.67%
Sales	0.45M	P/S	192.53	EPS this Y	-	Inst Trans	-18.34%	Short Ratio	0.22	Perf Half Y	31.03%
Book/sh	0.43	P/B	14.01	EPS next Y	-	ROA	-15.83%	Short Interest	0.03M	Perf Year	-
Cash/sh	0.43	P/C	14.06	EPS next 5Y	-	ROE	-20.35%	52W Range	1.32 - 6.45	Perf YTD	37.87%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-10.68%	52W High	-5.74%	Beta	-
Dividend TTM	-	Quick Ratio	12.18	Sales past 5Y	-13.17%	Gross Margin	85.04%	52W Low	360.61%	ATR (14)	0.73
Dividend Ex-Date	-	Current Ratio	12.40	EPS Y/Y TTM	-177.11%	Oper. Margin	-171.86%	RSI (14)	67.53	Volatility	12.81% 9.02%
Employees	-	Debt/Eq	0.04	Sales Y/Y TTM	-28.70%	Profit Margin	-147.39%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	-141.28%	Payout	-	Rel Volume	1.18	Prev Close	5.40
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-34.30%	Earnings	-	Avg Volume	158.65K	Price	6.08
SMA20	37.11%	SMA50	58.71%	SMA200	54.39%	Trades		Volume	186,806	Change	12.59%

Mar-17-25 08:31AM	Why Pheton Holdings Ltd. (PTHL) Soared Last Week? (Insider Monkey) -12.20%
Sep-06-24 04:08PM	Pheton Holdings Ltd Announces Closing of Initial Public Offering (GlobeNewswire) -9.23%
Sep-05-24 09:31AM	Pheton Holdings Ltd Announces Pricing of Initial Public Offering (GlobeNewswire)

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PTHL

Pheton Holdings Ltd

Upgrade your FINVIZ experience